NDC 50090-7186-01 - Carbidopa and Levodopa
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 50090-7186
- Requested NDC
- 50090-7186-01
- Package NDCs from labels
- 50090-7186-0, 50090-7186-1, 50090-7186-01
- Manufacturer
- A-S Medication Solutions
- Effective date
- 2024-06-28
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Carbidopa and Levodopa - A-S Medication Solutions | A-S Medication Solutions | 2024-06-28 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 50090-7186-0 | Carbidopa and Levodopa | 30 in 1 BOTTLE | TABLET | 30 | 4 | |
| 50090-7186-1 | Carbidopa and Levodopa | 90 in 1 BOTTLE | TABLET | 90 | 4 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 50090-7186 | CARBIDOPA AND LEVODOPA TABLET [A-S MEDICATION SOLUTIONS] | 4 | Current NDC, 2 package rows | 20240629_84831a49-02d8-421e-8f05-f1358d7149cb.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 50090-7186-0 | EA - Each | 50090-7186 | 5c001e98-6191-414d-9694-93a0b3bf7f7d | 1 | 2024-08-12 |
| 50090-7186-1 | EA - Each | 50090-7186 | 30308616-fbb9-4019-9c1f-61314b4f40e9 | 1 | 2024-08-12 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Carbidopa | CARBIDOPA | Aurobindo Pharma Limited | ed98c7e1-78a6-43a5-92cd-4f085af6f09d | 2021-04-29 | Warnings, Adverse reactions | MNX7R8C5VO |
| Carbidopa | CARBIDOPA TABLETS | Oceanside Pharmaceuticals | d5204e5e-10ef-4758-8fc6-cb710048c687 | 2020-07-02 | Warnings, Adverse reactions | MNX7R8C5VO |
| Lodosyn | CARBIDOPA | Bausch Health US, LLC | ff8e105b-7415-42d4-bbb2-b36cfb8945a5 | 2020-07-01 | Warnings, Adverse reactions | MNX7R8C5VO |
| Carbidopa and Levodopa | CARBIDOPA AND LEVODOPA | Alembic Pharmaceuticals Limited | a85a56c5-44dd-41d4-ac1c-bdc4758406a4 | 2019-06-06 | Warnings, Adverse reactions | MNX7R8C5VO 46627O600J |
| Neuro-Pro T007 | GABA, L-DOPA, NOREPINEPHRINE, SEROTONIN, ADRENOCORTICOTROPHIN, ANACARDIUM ORIENTALE, ARSENICUM ALBUM, BARYTA CARBONICA, CALCAREA CARBONICA, CALCAREA PHOSPHORICA, HYOSCYAMUS NIGER, LYCOPODIUM CLAVATUM, STRAMONIUM | Guangzhou Renuma Medical Systems Co., Ltd | 7e02ab0c-9bc2-4ffe-926c-5b388a07f7b2 | 2017-10-18 | Warnings | 46627O600J |
| Carbidopa | CARBIDOPA | Novel Laboratories, Inc. | 7e5c9666-7a7c-4b64-87e4-7be6ae53603e | 2017-06-01 | Warnings, Adverse reactions | MNX7R8C5VO |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.